Intellia Therapeutics, Inc. - Filer Information

Symbol
NTLA on Nasdaq
Entity
Company
CIK
0001652130
EIN
364785571
Business address
40 Erie Street, Suite 130, 02139 Cambridge, MA
Phone
857-285-6200
State of incorporation
DE
Fiscal year end
December 31
Category
Large accelerated filer
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company